Abstract 3014: Targeting PLXND1 using RNA bioengineering technologies and customized lipid nanoparticles in advanced prostate cancer
Year: 2026
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148835518
Cites:
Cited by:
Related to:
